Financial Analysis
Filing-based analysis. Market pricing is not included. Fundamentals from SEC filings; economic data from FRED and the BLS. About our data
Filing evidence summary
Mixed evidenceCoverage 4/5 core metricsLatest reported annual revenue changed -18.7% from the prior reported annual observation.
Backward-looking filed evidence under visible rules - not a rating, forecast or investment advice. Missing data is never scored.
Evidence signals
- Revenue contracted
Latest reported annual revenue changed -18.7% from the prior reported annual observation.
Why this surfaced
Direction threshold: above +2% constructive; below -2% caution; otherwise monitor. This is not labeled one-year growth when filing periods have a gap. Period end 2025-12-31.
- Free cash flow was negative
Latest reported free cash flow was -$24M.
Why this surfaced
Free cash flow = operating cash flow minus capital expenditures; positive is supporting evidence, not a valuation conclusion. Period end 2025-12-31.
- 4 filing risk checks flagged
Flagged areas: Earnings quality, Solvency & liquidity.
Why this surfaced
The full financial analysis shows each value, threshold, and sector limitation.
- Operating margin improved
Operating margin changed +4.1 percentage points from the prior annual period.
Why this surfaced
Direction threshold: more than +1 percentage point constructive; below -1 point caution. Period end 2025-12-31.
Core trend metrics
Hover a tile for its exact definition; the Statements tab carries per-cell filing citations.
Where to look next
Risk checks
- Earnings quality
- Solvency & liquidity
Financial movement
- Cash→ flat
- Long-term debt→ flat
- Inventory→ flat
- Receivables→ flat
- Current assets→ flat
Source & freshness
- Source
- SEC EDGAR XBRL
- Fetched
- 2026-11-22
- Latest period end
- 2025-12-31
- Filings
- EDGAR ↗
Reported segment mix
figures as filed · share of the filed sum · change vs the prior period in the same filing- Hardware$545M83.7%-21.5% yoy
- Subscription And Services$106M16.3%-0.6% yoy
Members sum to the consolidated $652M for this period.
- Americas$383Mshare n/a+1.2% yoy
- United States$310Mshare n/a+6.5% yoy
- EMEA$191Mshare n/a-26.3% yoy
- Asia Pacific$77.3Mshare n/a-52.8% yoy
member sum exceeds the consolidated figure: this axis carries more than one breakdown, so shares are not computed.
- Hardware$76M72.4%no prior
- Subscription And Services$29M27.6%no prior
Change is against the same quarter a year earlier, as reported in the same 10-Q.
Source: SEC DERA Financial Statement and Notes data sets. Dimensional XBRL facts on the business-segment, product/service and geographic axes; the engine keeps the accession of every figure. Descriptive and educational, not advice.
Peer percentiles
latest fiscal year ending 2025-12-31 · among 4,026 US-listed filers · 307 in Healthcare| Metric | Value | vs all filers | vs sector |
|---|---|---|---|
Revenue latest fiscal-year revenue as filed | $652M | 47thof 3,198 middle third | 58thof 280 middle third |
Revenue growth latest fiscal-year revenue vs the prior fiscal year | -18.7% | 7thof 3,041 bottom third | 5thof 268 bottom third |
Gross margin gross profit ÷ revenue | 33.6% | 43rdof 1,557 middle third | 20thof 203 bottom third |
Operating margin operating income ÷ revenue | -12.8% | 30thof 2,733 bottom third | 40thof 268 middle third |
Net margin net income ÷ revenue | -14.3% | 27thof 3,157 bottom third | 40thof 279 middle third |
Free-cash-flow margin (operating cash flow − |capex|) ÷ revenue | -3.7% | 28thof 2,598 bottom third | 41stof 252 middle third |
Return on equity net income ÷ stockholders' equity (positive equity only) | -122.1% | 10thof 3,488 bottom third | 17thof 279 bottom third |
Stock comp ÷ revenue stock-based compensation ÷ revenue · lower is ranked higher | 3.0% | 44thof 2,809 middle third | 52ndof 266 middle third |
Days sales outstanding receivables ÷ revenue × 365 · lower is ranked higher | 52 days | 45thof 2,340 middle third | 58thof 255 middle third |
Cash-flow accrual ratio (net income − operating cash flow) ÷ average total assets · lower is ranked higher | -15.0% | 82ndof 3,803 top third | 79thof 295 top third |
Balance-sheet accrual ratio change in net operating assets ÷ average net operating assets · lower is ranked higher | 37.2% | 21stof 3,262 bottom third | 20thof 256 bottom third |
Each filer's latest fiscal year as stored by the nightly crawl; fiscal year ends differ across the universe. A metric ranks only filers for which it is computable from filed facts. Ties split; a rank reads "better than N% of filers" in the metric's own direction. Descriptive and educational, not a rating.
Earnings quality
latest fiscal year ending 2025-12-31 · accruals and cash conversion as filedPer fiscal year from filed facts: cash conversion = operating cash flow / net income (net income > 0); cash-flow accrual ratio = (net income - operating cash flow) / average total assets; balance-sheet accrual ratio = change in net operating assets / average net operating assets, NOA = (assets - cash) - (liabilities - debt). Descriptive; a missing input yields a missing ratio. High accrual ratios and cash conversion well below one are the measures the accruals literature associates with less persistent earnings; they are screens to read the cash-flow statement with, not conclusions. The per-year series is part of Pro risk analysis.
Point-in-time ledger
first-reported vs latest filing · periods since 2020-01-01 · 12 changed periods| Line item | Period | First reported | Latest filing | Change | Filings |
|---|---|---|---|---|---|
| Stockholders' equity StockholdersEquity | balance at 2026-03-31 | -$1.87M 10-Q 2026-05-11 | $3.48M 10-Q 2026-11-16 | +286.3% | first · latest · 5 filings carry it |
| Net income NetIncomeLoss | quarter 2025-09-30 | -$21.3M 10-Q 2025-11-06 | -$27.4M 10-Q 2026-11-16 | -29.0% | first · latest · 3 filings carry it |
| Long-term debt LongTermDebt | balance at 2025-12-31 | $44.3M 10-K 2026-03-12 | $36.6M 10-Q 2026-11-16 | -17.3% | first · latest · 7 filings carry it |
| Long-term debt LongTermDebt | balance at 2025-09-30 | $43.9M 10-Q 2025-11-06 | $36.3M 10-Q 2026-11-16 | -17.3% | first · latest · 3 filings carry it |
| Stockholders' equity StockholdersEquity | balance at 2026-06-30 | -$32.7M 10-Q 2026-08-10 | -$29.3M 10-Q 2026-11-16 | +10.3% | first · latest · 3 filings carry it |
| Stockholders' equity StockholdersEquity | balance at 2025-09-30 | $80.5M 10-Q 2025-11-06 | $74.3M 10-Q 2026-11-16 | -7.7% | first · latest · 3 filings carry it |
| Net income NetIncomeLoss | quarter 2026-03-31 | -$80.8M 10-Q 2026-05-11 | -$76.3M 10-Q 2026-11-16 | +5.6% | first · latest · 5 filings carry it |
| Total liabilities Liabilities | balance at 2026-03-31 | $383M 10-Q 2026-05-11 | $378M 10-Q/A 2026-10-19 | -1.4% | first · latest |
| Total liabilities Liabilities | balance at 2025-09-30 | $458M 10-Q 2025-11-06 | $464M 10-Q 2026-11-16 | +1.4% | first · latest · 3 filings carry it |
| Stockholders' equity StockholdersEquity | balance at 2025-12-31 | $76.5M 10-K 2026-03-12 | $77.4M 10-Q 2026-11-16 | +1.1% | first · latest · 7 filings carry it |
| Net income NetIncomeLoss | fiscal year 2025-12-31 | -$93.5M 10-K 2026-03-12 | -$92.6M 10-K/A 2026-10-19 | +0.9% | first · latest |
| Total liabilities Liabilities | balance at 2026-06-30 | $431M 10-Q 2026-08-10 | $428M 10-Q/A 2026-10-19 | -0.8% | first · latest |
First filing reporting each period vs the latest filing carrying it (10-K and 10-Q only, periods since 2020, the extractor's winning tag per concept); a change under 0.5% is treated as rounding; share counts re-presented by an integer split ratio are listed as split adjustments, not restatements. A change can be a restatement, a reclassification or a re-tagging in a later comparative column; the two filings are linked so the reader can see which. Descriptive, not a verdict.
Notes by disclosure type
debt, leases, revenue, segments, contingencies, taxes and more · the filer's own wordsBusiness combinations · 824 characters as filed
, the Company completed an acquisition of Forcite Helmet Systems, a privately-held company that offers technology-enabled helmets, for total consideration of $14.0 million. The allocation of the purchase price primarily included $7.5 million in developed technology and $5.9 million of residual goodwill. Net tangible assets acquired were not material. Goodwill is primarily attributable to expected synergies in the technologies that can be leveraged by the Company in future product offerings. The operating results of the acquired entity have been included in the Companys consolidated financial statements from the date of acquisition. Actual and pro forma results of operations for this acquisition have not been presented because they did not have a material impact to the Companys consolidated financial statements. …
BusinessCombinationDisclosureTextBlock · excerpt; the full note is in the filing
Employee benefit plans · 8,274 characters as filed
8. Employee benefit plans Equity incentive plans . The Company has outstanding equity grants from four of its five stock-based employee compensation plans: the 2024 Equity Incentive Plan (2024 Plan), the 2014 Equity Incentive Plan (2014 Plan), the 2010 Equity Incentive Plan (2010 Plan), and the 2024 Employee Stock Purchase Plan (2024 ESPP). The 2024 Plan serves as a successor to the 2014 Plan and the 2014 Plan served as successor to the 2010 Plan. The effective date of both the 2024 Plan and the 2024 ESPP was February 15, 2024. The 2014 Plan and the 2014 Employee Stock Purchase Plan (2014 ESPP) each expired on February 15, 2024. The 2014 ESPP plans final purchase was on February 15, 2024, and no remaining purchase rights are accrued under this plan. Awards granted under the 2010 and 2014 Plans will continue to be subject to the terms and provisions of the 2010 and 2014 Plans. The 2024 Plan provides for the granting of incentive and non-qualified stock options, restricted stock awards (RSAs), restricted stock units (RSUs), stock appreciation rights, stock bonus awards (SBAs) and performance awards to qualified employees, non-employee directors and consultants. Options granted under the 2024 Plan generally expire within ten years from the date of grant and generally vest over one to four years. RSUs granted under the 2024 Plan generally vest over two to four years based upon continued service and are settled at vesting in shares of the Companys Class A common stock. Performance …
CompensationAndEmployeeBenefitPlansTextBlock · excerpt; the full note is in the filing
Debt · 17,122 characters as filed
6. Financing arrangements 2021 Credit Facility In January 2021, the Company entered into a Credit Agreement which provides for a revolving credit facility (2021 Credit Facility) under which the Company may borrow up to an aggregate amount of $35.0 million from the February 2026 amendment to the Borrowing Base Conversion Date, which is considered when the Company completes an appraisal and other collateral diligence measures in order to implement a borrowing base to tie usage of the 2021 Credit Facility to the Companys collateral value, and up to $50.0 million thereafter. In March 2023, August 2025 and February 2026, the Company amended the 2021 Credit Agreement (collectively, the 2021 Credit Agreement). The February 2026 amendment extended the maturity of the 2021 Credit Agreement to June 2027, changed the interest rate at which borrowed funds accrued interest and changed the liquidity minimums, all of which are discussed below. Upon termination of the 2021 Credit Agreement in June 2027, any outstanding borrowings will become due and payable. Prior to the Borrowing Base Conversion Date, the amount that may be borrowed under the 2021 Credit Agreement is $35.0 million, unless the Companys Asset Coverage Ratio is less than 1.50, which would subject the amount that may be borrowed to a customary borrowing base calculation. The Asset Coverage Ratio is defined as the ratio of (i) the sum of (a) the Companys cash and cash equivalents in the United States plus specified percentages o …
DebtDisclosureTextBlock · excerpt; the full note is in the filing
Fair value · 4,584 characters as filed
Fair value measurements The Companys assets and liabilities that are measured at fair value on a recurring basis within the fair value hierarchy are summarized as follows: December 31, 2025 December 31, 2024 (in thousands) Level 1 Level 2 Level 3 Total Level 1 Level 2 Level 3 Total (As Restated) Cash equivalents (1) : Money market funds $ 40,120 $ $ $ 40,120 $ 42,436 $ $ $ 42,436 Total cash equivalents $ 40,120 $ $ $ 40,120 $ 42,436 $ $ $ 42,436 Other long-term liabilities Warrant liability $ $ $ 13,090 $ 13,090 $ $ $ $ Total other long-term liabilities $ $ $ 13,090 $ 13,090 $ $ $ $ (1) Included in cash and cash equivalents in the accompanying consolidated balance sheets. Cash balances were $9.6 million and $60.4 million as of December 31, 2025 and 2024, respectively. The Company corrected errors in the valuation of the warrant liability and in the accounting for the November 5, 2025 warrant repricing. See Note 2. Restatement of previously issued consolidated financial statements, for the nature and quantitative effects of these corrections. Cash equivalents are classified as Level 1 because the Company uses quoted market prices to determine their fair value. As of December 31, 2025 and 2024, the amortized cost of the Companys cash equivalents approximated their fair value and there were no material realized or unrealized gains or losses, either individually or in the aggregate. The liability-classified warrants are classified as Level 3 and are valued based on a Black-Schole …
FairValueDisclosuresTextBlock · excerpt; the full note is in the filing
Income taxes · 9,337 characters as filed
10. Income taxes As described in Note 2 Restatement of previously issued consolidated financial statements, the restatement decreased the Company's 2025 United States loss before income taxes by $0.8 million, with a corresponding change in the deferred tax asset for United States federal and state net operating loss carryforwards and the related valuation allowance. Because the Company maintains a full valuation allowance on its United States federal and state net deferred tax assets, the restatement had no effect on income tax expense (benefit). Income (loss) before income taxes consisted of the following: Year ended December 31, (in thousands) 2025 2024 2023 (As Restated) United States $ (99,041) $ (142,195) $ (79,514) Foreign 8,435 9,106 11,781 Loss before income taxes $ (90,606) $ (133,089) $ (67,733) Income tax expense (benefit) consisted of the following: Year ended December 31, (in thousands) 2025 2024 2023 Current Federal $ 1 $ 1 $ 3 State 72 (28) 162 Foreign 1,689 2,478 3,176 Total current $ 1,762 $ 2,451 $ 3,341 Deferred Federal $ 87 $ 222,087 $ (14,018) State 74,886 (3,828) Foreign 190 (202) (45) Total deferred $ 277 $ 296,771 $ (17,891) Total income tax expense (benefit) Federal $ 88 $ 222,088 $ (14,015) State 72 74,858 (3,666) Foreign 1,879 2,276 3,131 Total income tax expense (benefit) $ 2,039 $ 299,222 $ (14,550) Income taxes paid (net of refunds) that equal or exceed 5% of total income taxes paid (net of refunds received) consisted of the following: Year ended …
IncomeTaxDisclosureTextBlock · excerpt; the full note is in the filing
Related parties · 1,408 characters as filed
Related party transactions On November 5, 2025, a trust affiliated with Nicholas Woodman, the Companys Chief Executive Officer and Chairman of the Board of Directors, entered into an agreement (the Subscription Agreement) to purchase an aggregate of $2.0 million of the Companys Class A common stock shares, par value $0.0001. Pursuant to the Subscription Agreement, the actual amount of Class A common stock shares to be issued were to be determined upon the calculation of the purchase price of the shares, which was calculated as the greater of the following variables: (a) the consolidated closing bid price (as determined pursuant to the rules of the Nasdaq Stock Market) immediately prior to entry into the Subscription Agreement or (b) the average closing price of the Class A common stock over the five (5) trading days prior to the date of issuance, as reported on the Nasdaq Global Select Market. On November 10, 2025, 1,129,944 shares of Class A common stock were issued at a price per share of $1.77, which price was based on the consolidated closing bid price, which was the greater of the two variables. The issuance of shares was included within common stock and additional paid-in capital on the consolidated balance sheets. The $2.0 million was paid to the Company in November 2025, and the Company had zero outstanding receivables from the Chief Executive Officer as of December 31, 2025. …
RelatedPartyTransactionsDisclosureTextBlock · excerpt; the full note is in the filing
Restructuring · 2,588 characters as filed
14. Restructuring charges Restructuring charges for each period were as follows: Year ended December 31, (in thousands) 2025 2024 2023 Cost of revenue $ 12 $ 755 $ (90) Research and development 1,430 16,585 687 Sales and marketing 542 5,310 130 General and administrative 2,060 1,762 11 Total restructuring charges $ 4,044 $ 24,412 $ 738 Third quarter 2024 restructuring In August 2024, the Company approved a restructuring plan (the Original Restructuring Plan) and in October 2024, the Company approved an amended restructuring plan (the Updated Restructuring Plan). In connection with the Original Restructuring Plan and Updated Restructuring Plan, the Company reduced its global workforce by 25% compared to its headcount ending Q2 2024, and recorded restructuring charges of $18.7 million including $12.7 million related to severance and $6.0 million of project cancellation costs. As of December 31, 2025, the Company expects to pay the remaining restructuring liability related to the Updated Restructuring Plan in cash. (in thousands) Severance Other Total Restructuring liability as of December 31, 2024 $ 2,535 $ 6,038 $ 8,573 Cash paid (2,216) (2,038) (4,254) Non-cash reductions (319) (319) Restructuring liability as of December 31, 2025 $ $ 4,000 $ 4,000 First quarter 2024 restructuring In March 2024, the Company approved a restructuring plan to reduce operating costs and drive stronger operating leverage by reducing the Companys global workforce by approximately 4% and closing cer …
RestructuringAndRelatedActivitiesDisclosureTextBlock · excerpt; the full note is in the filing
Subsequent events · 17,029 characters as filed
"On February 27, 2026, the Company amended the 2021 Credit Agreement and 2025 Credit Agreement, as referenced in Note 6 Financing arrangements. On February 27, 2026, the Company entered into a securities purchase agreement (Securities Purchase Agreement) with YA II PN, Ltd. (YA II PN), a fund of Yorkville Advisors Global, LP in connection with the issuance and sale by the Company of convertible debentures (the Convertible Debentures) issuable in an aggregate principal amount of up to $50.0 million, which Convertible Debentures will be convertible into shares of the Companys Class A common stock, par value $0.0001 per share (the Common Stock) (as converted, the Conversion Shares). Conversion of the Convertible Debentures will dilute the ownership interests of existing stockholders. Pursuant to the Securities Purchase Agreement, YA II PN purchased $25.0 million in aggregate principal amount of Convertible Debentures on the signing of the Securities Purchase Agreement. At the Companys discretion, YA II PN may purchase and the Company may issue an additional $5.0 million on the day prior to the filing of a registration statement with the SEC. At the Companys discretion, YA II PN may purchase and the Company may issue an additional $20.0 million in aggregate principal amount of Convertible Debentures on or about the second business day following the satisfaction of certain closing conditions. The Convertible Debentures accrue interest at 0% per annum, unless (i) certain interest r …
SubsequentEventsTextBlock · excerpt; the full note is in the filing
Employee benefit plans · 6,464 characters as filed
6. Employee benefit plans Equity incentive plans . The Company has outstanding equity grants from four of its five stock-based employee compensation plans: the 2024 Equity Incentive Plan, as amended (2024 Plan), the 2014 Equity Incentive Plan (2014 Plan), the 2010 Equity Incentive Plan (2010 Plan), and the 2024 Employee Stock Purchase Plan (2024 ESPP). The 2024 Plan serves as a successor to the 2014 Plan and the 2014 Plan served as successor to the 2010 Plan. The original effective date of both the 2024 Plan and the 2024 ESPP was February 15, 2024 and the 2024 Plan was amended on June 2, 2026, which increased the number of shares of Class A common stock authorized for issuance under the 2024 Plan by 13,000,000 shares. The 2014 Plan and the 2014 Employee Stock Purchase Plan (2014 ESPP) each expired on February 15, 2024. The 2014 ESPP plans final purchase was on February 15, 2024, and no remaining purchase rights are accrued under this plan. Awards granted under the 2010 and 2014 Plans will continue to be subject to the terms and provisions of the 2010 and 2014 Plans. The 2024 Plan provides for the granting of incentive and non-qualified stock options, restricted stock awards (RSAs), restricted stock units (RSUs), stock appreciation rights, stock bonus awards (SBAs) and performance awards to qualified employees, non-employee directors and consultants. Options granted under the 2024 Plan generally expire within ten years from the date of grant and generally vest over one to four …
CompensationAndEmployeeBenefitPlansTextBlock · excerpt; the full note is in the filing
Debt · 36,988 characters as filed
4. Financing arrangements 2021 Credit Agreement In January 2021, the Company entered into a credit agreement which provides for a revolving credit facility (2021 Credit Facility) and the Company amended the credit agreement in March 2023, August 2025 and February 2026. Additionally, on July 9, 2026, the Company entered into a Waiver and Amendment No. 4 to the credit agreement (as amended, collectively, the 2021 Credit Agreement). Under the 2021 Credit Agreement, the Company may borrow up to an aggregate amount of $35.0 million (subject to an asset coverage ratio requirement of 1.5x), which with the February 2026 amendment, the testing of the asset coverage ratio changed from quarterly to monthly, until the Borrowing Base Conversion Date, which was June 30, 2026 (the date on which the lender implemented a borrowing base following the completion of an appraisal, field exam and other collateral diligence measures). The asset coverage ratio is defined as the ratio of (i) the sum of (a) the Companys cash and cash equivalents in the United States plus specified percentages of other qualified debt investments (Qualified Cash) plus (b) specified percentages of the net book values of the Companys accounts receivable and certain inventory to (ii) $50.0 million. After the Borrowing Base Conversion Date, which was June 30, 2026, the amount that may be borrowed under the 2021 Credit Agreement is based on a customary borrowing base calculation, and up to $50.0 million with zero currently a …
DebtDisclosureTextBlock · excerpt; the full note is in the filing
Fair value · 5,755 characters as filed
Fair value measurements The Companys assets and liabilities that are measured at fair value on a recurring basis within the fair value hierarchy are summarized as follows: June 30, 2026 December 31, 2025 (in thousands) Level 1 Level 2 Level 3 Total Level 1 Level 2 Level 3 Total (As Restated) Cash equivalents (1) : Money market funds $ 17,141 $ $ $ 17,141 $ 40,120 $ $ $ 40,120 Total cash equivalents $ 17,141 $ $ $ 17,141 $ 40,120 $ $ $ 40,120 Liabilities: Derivative liabilities $ $ 19,233 $ 4,500 $ 23,733 $ $ $ $ Warrant liability 6,774 6,774 13,090 13,090 Total liabilities $ $ 19,233 $ 11,274 $ 30,507 $ $ $ 13,090 $ 13,090 (1) Included in cash and cash equivalents in the accompanying condensed consolidated balance sheets. Cash balances were $10.1 million and $9.6 million as of June 30, 2026 and December 31, 2025, respectively. The Company corrected errors in the valuation of the warrant liability, and in the valuation of the derivative liability associated with the Convertible Debentures conversion feature. See Note 1A. Restatement of previously issued consolidated financial statements, for the nature and quantitative effects of these corrections. Cash equivalents are classified as Level 1 because the Company uses quoted market prices to determine their fair value. As of June 30, 2026 and December 31, 2025, the amortized cost of the Companys cash equivalents approximated their fair value and there were no material realized or unrealized gains or losses, either individually or …
FairValueDisclosuresTextBlock · excerpt; the full note is in the filing
Income taxes · 7,262 characters as filed
8. Income taxes The following table provides the income tax expense amount: Three months ended June 30, Six months ended June 30, (dollars in thousands) 2026 2025 2026 2025 Income tax expense $ 796 $ 1,309 $ 2,641 $ 2,961 The Company recorded an income tax expense of $0.8 million for the three months ended June 30, 2026 on a pre-tax net loss of $50.4 million, as restated. The restatement adjustments described in Note 1A. Restatement of previously issued consolidated financial statements, did not change the income tax expense because the Company maintains a full valuation allowance on its United States federal and state net deferred tax assets. The Companys income tax expense for the three months ended June 30, 2026 primarily resulted from a tax expense of $1.2 million on pre-tax book income in certain tax jurisdictions, partially offset by a tax benefit on foreign provision to income tax return adjustments of $0.5 million. The Company recorded an income tax expense of $2.6 million for the six months ended June 30, 2026 on a pre-tax net loss of $124.8 million. The Companys income tax expense for the six months ended June 30, 2026 primarily resulted from a tax expense of $2.4 million on pre-tax book income in certain tax jurisdictions and discrete items that included $1.2 million of nondeductible equity tax expense for employee stock-based compensation and $0.6 million from the establishment of a valuation allowance on foreign deferred tax assets due to the substantial doubt ab …
IncomeTaxDisclosureTextBlock · excerpt; the full note is in the filing
Related parties · 2,492 characters as filed
Related party transactions On November 5, 2025, a trust affiliated with Nicholas Woodman, the Companys Chief Executive Officer and Chairman of the Board of Directors, entered into an agreement (the Subscription Agreement) to purchase an aggregate of $2.0 million of the Companys Class A common stock shares, par value $0.0001. Pursuant to the Subscription Agreement, the actual amount of Class A common stock shares to be issued were to be determined upon the calculation of the purchase price of the shares, which was calculated as the greater of the following variables: (a) the consolidated closing bid price (as determined pursuant to the rules of the Nasdaq Stock Market) immediately prior to entry into the Subscription Agreement or (b) the average closing price of the Class A common stock over the five (5) trading days prior to the date of issuance, as reported on the Nasdaq Global Select Market. On November 10, 2025, 1,129,944 shares of Class A common stock were issued at a price per share of $1.77, which price was based on the consolidated closing bid price, which was the greater of the two variables. The issuance of shares was included within common stock and additional paid-in capital on the condensed consolidated balance sheets. The $2.0 million was paid to the Company in November 2025, and the Company had zero outstanding receivables from the Chief Executive Officer as of December 31, 2025. On July 9, 2026, the Company closed the sale of the 2026 Notes and the 2026 Warrant …
RelatedPartyTransactionsDisclosureTextBlock · excerpt; the full note is in the filing
Restructuring · 2,491 characters as filed
12. Restructuring charges Restructuring charges for each period were as follows: Three months ended June 30, Six months ended June 30, (in thousands) 2026 2025 2026 2025 Cost of revenue $ 97 $ (1) $ 106 $ 1 Research and development 1,637 (426) 1,640 336 Sales and marketing 350 32 344 509 General and administrative 223 684 278 1,873 Total restructuring charges $ 2,307 $ 289 $ 2,368 $ 2,719 Second quarter 2026 restructuring In April 2026, the Company approved a restructuring plan (the Second Quarter 2026 Restructuring Plan) to reduce its global workforce by approximately 23% compared to its headcount as of March 31, 2026. In the second quarter of 2026, the Company began implementing the Second Quarter 2026 Restructuring Plan and recorded $2.2 million of severance charges. At the time of approval of the Second Quarter 2026 Restructuring Plan, the Company expected to incur an aggregate severance charge in the range of $11.5 million to $15.0 million that would be substantially complete by the end of 2026. However, given the events described in Note 1 Summary of business and significant accounting policies, the Company is currently unable in good faith to estimate the amount, or range of amounts, expected to be incurred in connection with the remainder of the Second Quarter 2026 Restructuring Plan or to estimate the timing of future cash expenditures. (in thousands) Severance Total Restructuring liability as of December 31, 2025 $ $ Restructuring charges 2,181 2,181 Cash paid (1,96 …
RestructuringAndRelatedActivitiesDisclosureTextBlock · excerpt; the full note is in the filing
Subsequent events · 10,196 characters as filed
Subsequent events 2026 Notes and 2026 Warrants On July 9, 2026, the Company closed the sale of the 2026 Notes and the 2026 Warrants contemplated by the Woodman Purchase Agreement, dated as of July 1, 2026, by and among the Company and certain entities (the Buyers) affiliated with Nicholas Woodman, the Companys Chief Executive Officer and Chairman of the Board of Directors. In connection with the closing, (i) the Company received $19.9 million in net proceeds in exchange for issuing the 2026 Notes in an aggregate principal amount of $20.0 million to the Buyers and (ii) the Company issued the 2026 Warrants exercisable for 25,706,940 shares of the Company's Class B common stock, par value $0.0001 per share. The 2026 Notes mature on July 21, 2028 and have an interest rate of 6.50% per annum, subject to adjustment after the occurrence and during the continuance of any event of default, which is payable semi-annually in kind through an increase to the principal amount of the 2026 Notes. The Company may redeem the 2026 Notes at its option in whole or in part at any time at a price in cash equal to the principal amount being redeemed plus accrued and unpaid interest to the redemption date (the Redemption Price). In addition, the Company is required to redeem the 2026 Notes at the Redemption Price upon the occurrence of certain events, including (i) the repayment in full of all amounts outstanding under the 2025 Credit Agreement, (ii) the receipt by the Company of cash proceeds from d …
SubsequentEventsTextBlock · excerpt; the full note is in the filing
Source: SEC DERA Financial Statement and Notes data sets (txt.tsv), excerpts of the filer's own note text; the full note is in the linked filing. Excerpts are the first part of each note exactly as tagged in the filing; open the filing for the full text and the tables. Descriptive and educational, not advice.
Fundamentals from SEC EDGAR. Scores, the DCF, and every model shown are educational analysis, not investment advice or price predictions.